| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-13 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |